About Bugworks Research
Bugworks Research is a company based in Saratoga (United States) founded in 2014 by Santanu Datta and Anand Anandkumar.. Bugworks Research has raised $42.89 million across 15 funding rounds from investors including NIH, Baxter and 3one4 Capital. Bugworks Research offers products and services including Antibacterial Agents and Oncology Therapeutics. Bugworks Research operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Saratoga, United States
- Founders Santanu Datta, Anand Anandkumar
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bugworks Research India Private Limited
- Date of Incorporation 04 Feb, 2014
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$3.34 M (USD)39.83as on Mar 31, 2023
-
Net Profit
$325.47 K (USD)-1as on Mar 31, 2023
-
EBITDA
$987.21 K (USD)26.61as on Mar 31, 2023
-
Total Equity Funding
$42.89 M (USD)
in 15 rounds
-
Latest Funding Round
$6.78 M (USD), Series B
Feb 22, 2024
-
Investors
NIH
& 19 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bugworks Research
Bugworks Research offers a comprehensive portfolio of products and services, including Antibacterial Agents and Oncology Therapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Novel small molecules targeting multidrug-resistant infections.
Small molecules for hypoxic and refractory solid tumors.
Unlock access to complete
Unlock access to complete
Funding Insights of Bugworks Research
Bugworks Research has successfully raised a total of $42.89M across 15 strategic funding rounds. The most recent funding activity was a Series B round of $6.78 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Series B — $6.8M
- First Round First Round
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series B - Bugworks Research | Valuation |
investors |
|
| Dec, 2021 | Amount | Series B - Bugworks Research | Valuation | Lightrock India | |
| Apr, 2021 | Amount | Grant - Bugworks Research | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bugworks Research
Bugworks Research has secured backing from 20 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include NIH, Baxter and 3one4 Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors like SaaS and Fintech in India.
|
Founded Year | Domain | Location | |
|
Global Brain is recognized as a venture capital firm supporting startups.
|
Founded Year | Domain | Location | |
|
Seed and Early stage VC firm investing in Japan
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bugworks Research
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bugworks Research
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bugworks Research Comparisons
Competitors of Bugworks Research
Bugworks Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bugworks Research
Frequently Asked Questions about Bugworks Research
When was Bugworks Research founded?
Bugworks Research was founded in 2014.
Where is Bugworks Research located?
Bugworks Research is headquartered in Saratoga, United States. It is registered at Saratoga, California, United States.
Who is the current CEO of Bugworks Research?
Anand Anandkumar is the current CEO of Bugworks Research. They have also founded this company.
Is Bugworks Research a funded company?
Bugworks Research is a funded company, having raised a total of $42.89M across 15 funding rounds to date.
What is the annual revenue of Bugworks Research?
Annual revenue of Bugworks Research is $3.34M as on Mar 31, 2023.
What does Bugworks Research do?
Bugworks Research was founded in 2014 in Saratoga, United States, within the biotechnology sector. Therapeutics targeting antibiotic-resistant bacterial infections and cancer are developed using the Microbial Platform (BMP), which models biofilm formation and bacterial behavior. A lead Gyrase-topoisomerase inhibitor is advanced for intravenous and oral treatments of multi-drug resistant infections, with mechanisms that inhibit two replication targets and circumvent bacterial efflux resistance.
Who are the top competitors of Bugworks Research?
Bugworks Research's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Bugworks Research offer?
Bugworks Research offers Antibacterial Agents and Oncology Therapeutics.
Who are Bugworks Research's investors?
Bugworks Research has 20 investors. Key investors include NIH, Baxter, 3one4 Capital, CARB-X, and UK Research and Innovation.